192 related articles for article (PubMed ID: 38084540)
1. COVID-19-associated mucormycosis - "The Black fungus" with associated invasive aspergillosis and actinomycosis infection: Series of 5 cases in the Indian scenario.
Menia R; Raychaudhuri S; Agarwal C; Taneja J
Indian J Pathol Microbiol; 2023; 66(4):823-828. PubMed ID: 38084540
[TBL] [Abstract][Full Text] [Related]
2. Invasive Mucormycosis and Aspergillosis Coinfection Associated with Post-COVID-19 Pneumonia in a Tertiary Care Hospital.
Paul M; Sasidharan J; Taneja J; Chatterjee K; Abbas SZ; Chowdhury V; Das A
Med Mycol J; 2022; 63(3):59-64. PubMed ID: 36047183
[TBL] [Abstract][Full Text] [Related]
3. COVID-19-associated mixed mold infection: A case report of aspergillosis and mucormycosis and a literature review.
Benhadid-Brahmi Y; Hamane S; Soyer B; Mebazaa A; Alanio A; Chousterman B; Bretagne S; Dellière S
J Mycol Med; 2022 Mar; 32(1):101231. PubMed ID: 34864498
[TBL] [Abstract][Full Text] [Related]
4. Mixed Aspergillosis and Mucormycosis Infections in Patients with COVID-19: Case Series and Literature Review.
Sasani E; Pakdel F; Khodavaisy S; Salehi M; Salami A; Sohrabi M; Aminishakiba P; Amirafzali I; Salami Khaneshan A
Mycopathologia; 2024 Jan; 189(1):10. PubMed ID: 38231407
[TBL] [Abstract][Full Text] [Related]
5. Isolated cerebral Mucormycosis and Aspergillosis coinfection in an immunocompromised adult.
Sun G; Weiss A; Zhao J; Silver M; DeMaio M; Dehbashi S
BMJ Case Rep; 2023 Aug; 16(8):. PubMed ID: 37640409
[TBL] [Abstract][Full Text] [Related]
6. Secondary infection with rhino-orbital cerebral mucormycosis associated with COVID-19.
Dallalzadeh LO; Ozzello DJ; Liu CY; Kikkawa DO; Korn BS
Orbit; 2022 Oct; 41(5):616-619. PubMed ID: 33752571
[TBL] [Abstract][Full Text] [Related]
7. [COVID-19 associated mucormycosis. A case in Argentina].
Aparicio M; Tuculet B; Rivolier MG; Forte A; Vila A
Medicina (B Aires); 2022; 82(2):304-307. PubMed ID: 35417397
[TBL] [Abstract][Full Text] [Related]
8. COVID-19 associated mucormycosis - An emerging threat.
Chao CM; Lai CC; Yu WL
J Microbiol Immunol Infect; 2022 Apr; 55(2):183-190. PubMed ID: 35074291
[TBL] [Abstract][Full Text] [Related]
9. COVID-19 associated mold infections: Review of COVID-19 associated pulmonary aspergillosis and mucormycosis.
Huang SF; Ying-Jung Wu A; Shin-Jung Lee S; Huang YS; Lee CY; Yang TL; Wang HW; Chen HJ; Chen YC; Ho TS; Kuo CF; Lin YT;
J Microbiol Immunol Infect; 2023 Jun; 56(3):442-454. PubMed ID: 36586744
[TBL] [Abstract][Full Text] [Related]
10. Maxillary mucormycosis and aspergillosis in post-COVID-19 patients in Mexico: A case series.
Urias-Barreras CM; Rodríguez-Archilla A; Canizalez-Roman A; Bastidas DA; León-Sicairos NM
J Stomatol Oral Maxillofac Surg; 2024 Feb; 125(1):101615. PubMed ID: 37648209
[TBL] [Abstract][Full Text] [Related]
11. Dual Fungal Infections (Aspergillosis and Mucormycosis) in a Diabetic Mellitus Patient Leading to Maxillary Sinusitis as a Post-COVID Manifestation: First Case Report.
Jawanda MK; Narula R; Gupta S; Sharma V; Gupta P; Kaur M
Acta Medica (Hradec Kralove); 2021; 64(4):227-231. PubMed ID: 35285446
[TBL] [Abstract][Full Text] [Related]
12. Fungal pathogens and COVID-19.
Singh A; Kaur A; Chowdhary A
Curr Opin Microbiol; 2023 Oct; 75():102365. PubMed ID: 37625261
[TBL] [Abstract][Full Text] [Related]
13. Increased Hospitalizations Involving Fungal Infections during COVID-19 Pandemic, United States, January 2020-December 2021.
Gold JAW; Adjei S; Gundlapalli AV; Huang YA; Chiller T; Benedict K; Toda M
Emerg Infect Dis; 2023 Jul; 29(7):1433-1437. PubMed ID: 37347805
[TBL] [Abstract][Full Text] [Related]
14. Fatal mucormycosis and aspergillosis coinfection associated with haemophagocytic lymphohistiocytosis: A case report and literature review.
Loubet D; Sarton B; Lelièvre L; Grouteau G; Iriart X; Chauvin P; Fillaux J; Valentin A; Berry A; Silva S; Bonneville F; Cassaing S; Guemas E
J Mycol Med; 2023 Mar; 33(1):101325. PubMed ID: 36270214
[TBL] [Abstract][Full Text] [Related]
15. Rhino-Orbital Cerebral Mucormycosis in Non-Diabetic Patients with COVID-19.
Elhamamsy S; Bayer T; Al-Kaffas M; Hatahet S; Grover M; Samdhani S; Nanda A; Gravenstein S
R I Med J (2013); 2021 Oct; 104(8):19-21. PubMed ID: 34582509
[TBL] [Abstract][Full Text] [Related]
16. Mucormycosis, past and present: a comprehensive review.
Gupta I; Baranwal P; Singh G; Gupta V
Future Microbiol; 2023 Feb; 18():217-234. PubMed ID: 36970978
[TBL] [Abstract][Full Text] [Related]
17. Aspergillosis and Mucormycosis in COVID-19 Patients: A Systematic Review.
Afzal S; Nasir M
J Coll Physicians Surg Pak; 2022 May; 32(5):639-645. PubMed ID: 35546702
[TBL] [Abstract][Full Text] [Related]
18. Long-term Outcome of Coronavirus Disease-associated Mucormycosis: 1-year Follow-up Study from India.
Agrawal P; Singh AP; Chakotiya PS; Kumar V; Gautam A; Kumar D
J Assoc Physicians India; 2024 Jun; 72(6):44-48. PubMed ID: 38881134
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of co-existent COVID-19-associated pulmonary aspergillosis (CAPA) and its impact on early mortality in patients with COVID-19-associated pulmonary mucormycosis (CAPM).
Muthu V; Agarwal R; Rudramurthy SM; Thangaraju D; Shevkani MR; Patel AK; Shastri PS; Tayade A; Bhandari S; Gella V; Savio J; Madan S; Hallur V; Maturu VN; Srinivasan A; Sethuraman N; Sibia RPS; Pujari S; Mehta R; Singhal T; Saxena P; Gupta V; Nagvekar V; Prayag P; Patel D; Xess I; Savaj P; Sehgal IS; Panda N; Rajagopal GD; Parwani RS; Patel K; Deshmukh A; Vyas A; Gandra RR; Sistla SK; Padaki PA; Ramar D; Panigrahi MK; Sarkar S; Rachagulla B; Vallandaramam P; Premachandran KP; Pawar S; Gugale P; Hosamani P; Dutt SN; Nair S; Kalpakkam H; Badhwar S; Kompella KK; Singla N; Navlakhe M; Prayag A; Singh G; Dhakecha P; Chakrabarti A
Mycoses; 2024 May; 67(5):e13745. PubMed ID: 38767273
[TBL] [Abstract][Full Text] [Related]
20. A systematic review on SARS-CoV-2-associated fungal coinfections.
Soni S; Namdeo Pudake R; Jain U; Chauhan N
J Med Virol; 2022 Jan; 94(1):99-109. PubMed ID: 34570905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]